APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Drug and Dietary Supplement

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global OTC Drug and Dietary Supplement Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchOTC Drug and Dietary Supplement Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Drug and Dietary Supplement Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal OTC Drug and Dietary Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Drug and Dietary Supplement Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Drug and Dietary Supplement Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global OTC Drug and Dietary Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the OTC Drug and Dietary Supplement market include Abbott, Pfizer, GSK, Bayer, Suntory, Reckitt Benckiser, Herbalife, Glanbia and Blackmores, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global OTC Drug and Dietary Supplement market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The OTC Drug and Dietary Supplement market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global OTC Drug and Dietary Supplement market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to OTC Drug and Dietary Supplement.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global OTC Drug and Dietary Supplement market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

OTC Drug and Dietary Supplement Market by Company

Abbott

Pfizer

GSK

Bayer

Suntory

Reckitt Benckiser

Herbalife

Glanbia

Blackmores

Amway

OTC Drug and Dietary Supplement Segment by Type

Powders

Capsules

Tablets

Liquids

OTC Drug and Dietary Supplement Segment by Application

Convenience Stores

Supermarkets

Pharmacies

OTC Drug and Dietary Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Drug and Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Drug and Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Drug and Dietary Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of OTC Drug and Dietary Supplement companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global OTC Drug and Dietary Supplement Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global OTC Drug and Dietary Supplement Market Size by Region (2021-2026) & (US$ Million) Table 3. Global OTC Drug and Dietary Supplement Market Share by Region (2021-2026) Table 4. Global OTC Drug and Dietary Supplement Market Size by Region (2027-2032) & (US$ Million) Table 5. Global OTC Drug and Dietary Supplement Market Share by Region (2027-2032) Table 6. Global OTC Drug and Dietary Supplement Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 8. Global OTC Drug and Dietary Supplement Market Size Share by Type (2021-2026) Table 9. Global OTC Drug and Dietary Supplement Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global OTC Drug and Dietary Supplement Market Size Share Forecasted by Type (2027-2032) Table 11. North America OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America OTC Drug and Dietary Supplement Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe OTC Drug and Dietary Supplement Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific OTC Drug and Dietary Supplement Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America OTC Drug and Dietary Supplement Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa OTC Drug and Dietary Supplement Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global OTC Drug and Dietary Supplement Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 23. Global OTC Drug and Dietary Supplement Market Size Share by Application (2021-2026) Table 24. Global OTC Drug and Dietary Supplement Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global OTC Drug and Dietary Supplement Market Size Share Forecasted by Application (2027-2032) Table 26. North America OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America OTC Drug and Dietary Supplement Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe OTC Drug and Dietary Supplement Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific OTC Drug and Dietary Supplement Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America OTC Drug and Dietary Supplement Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa OTC Drug and Dietary Supplement Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. OTC Drug and Dietary Supplement Industry Trends Table 37. OTC Drug and Dietary Supplement Industry Drivers Table 38. OTC Drug and Dietary Supplement Industry Opportunities and Challenges Table 39. OTC Drug and Dietary Supplement Industry Restraints Table 40. Global OTC Drug and Dietary Supplement Revenue by Company (US$ Million) & (2021-2026) Table 41. Global OTC Drug and Dietary Supplement Revenue Market Share by Company (2021-2026) Table 42. Global OTC Drug and Dietary Supplement Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global OTC Drug and Dietary Supplement Key Company Headquarters & Area Served Table 44. Global OTC Drug and Dietary Supplement Company, Product Type & Application Table 45. Global OTC Drug and Dietary Supplement Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global OTC Drug and Dietary Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Abbott Company Information Table 49. Abbott Business Overview Table 50. Abbott OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Abbott OTC Drug and Dietary Supplement Product Portfolio Table 52. Abbott Recent Development Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Pfizer OTC Drug and Dietary Supplement Product Portfolio Table 57. Pfizer Recent Development Table 58. GSK Company Information Table 59. GSK Business Overview Table 60. GSK OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GSK OTC Drug and Dietary Supplement Product Portfolio Table 62. GSK Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bayer OTC Drug and Dietary Supplement Product Portfolio Table 67. Bayer Recent Development Table 68. Suntory Company Information Table 69. Suntory Business Overview Table 70. Suntory OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Suntory OTC Drug and Dietary Supplement Product Portfolio Table 72. Suntory Recent Development Table 73. Reckitt Benckiser Company Information Table 74. Reckitt Benckiser Business Overview Table 75. Reckitt Benckiser OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio Table 77. Reckitt Benckiser Recent Development Table 78. Herbalife Company Information Table 79. Herbalife Business Overview Table 80. Herbalife OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Herbalife OTC Drug and Dietary Supplement Product Portfolio Table 82. Herbalife Recent Development Table 83. Glanbia Company Information Table 84. Glanbia Business Overview Table 85. Glanbia OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Glanbia OTC Drug and Dietary Supplement Product Portfolio Table 87. Glanbia Recent Development Table 88. Blackmores Company Information Table 89. Blackmores Business Overview Table 90. Blackmores OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Blackmores OTC Drug and Dietary Supplement Product Portfolio Table 92. Blackmores Recent Development Table 93. Amway Company Information Table 94. Amway Business Overview Table 95. Amway OTC Drug and Dietary Supplement Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Amway OTC Drug and Dietary Supplement Product Portfolio Table 97. Amway Recent Development Table 98. North America OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America OTC Drug and Dietary Supplement Market Size by Country (2021-2026) & (US$ Million) Table 100. North America OTC Drug and Dietary Supplement Market Share by Country (2021-2026) Table 101. North America OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America OTC Drug and Dietary Supplement Market Share Forecast by Country (2027-2032) Table 103. Europe OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe OTC Drug and Dietary Supplement Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe OTC Drug and Dietary Supplement Market Share by Country (2021-2026) Table 106. Europe OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe OTC Drug and Dietary Supplement Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Country (2021-2026) Table 111. Asia-Pacific OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific OTC Drug and Dietary Supplement Market Share Forecast by Country (2027-2032) Table 113. Latin America OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America OTC Drug and Dietary Supplement Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America OTC Drug and Dietary Supplement Market Share by Country (2021-2026) Table 116. Latin America OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America OTC Drug and Dietary Supplement Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country (2021-2026) Table 121. Middle East & Africa OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa OTC Drug and Dietary Supplement Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. OTC Drug and Dietary Supplement Product Image Figure 3. Global OTC Drug and Dietary Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 5. Global OTC Drug and Dietary Supplement Market Share by Region: 2025 VS 2032 Figure 6. Global OTC Drug and Dietary Supplement Market Share by Region (2021-2032) Figure 7. North America OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Powders Image Figure 13. Global Powders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Capsules Image Figure 15. Global Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Tablets Image Figure 17. Global Tablets Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Liquids Image Figure 19. Global Liquids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global OTC Drug and Dietary Supplement Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global OTC Drug and Dietary Supplement Market Share by Type 2025 VS 2032 Figure 22. North America OTC Drug and Dietary Supplement Market Size Share by Type (2021-2032) Figure 23. Europe OTC Drug and Dietary Supplement Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific OTC Drug and Dietary Supplement Market Size Share by Type (2021-2032) Figure 25. Latin America OTC Drug and Dietary Supplement Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa OTC Drug and Dietary Supplement Market Size Share by Type (2021-2032) Figure 27. Convenience Stores Image Figure 28. Global Convenience Stores Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Supermarkets Image Figure 30. Global Supermarkets Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Pharmacies Image Figure 32. Global Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global OTC Drug and Dietary Supplement Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global OTC Drug and Dietary Supplement Market Share by Application 2025 VS 2032 Figure 35. North America OTC Drug and Dietary Supplement Market Size Share by Application (2021-2032) Figure 36. Europe OTC Drug and Dietary Supplement Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific OTC Drug and Dietary Supplement Market Size Share by Application (2021-2032) Figure 38. Latin America OTC Drug and Dietary Supplement Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa OTC Drug and Dietary Supplement Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 OTC Drug and Dietary Supplement Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America OTC Drug and Dietary Supplement Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America OTC Drug and Dietary Supplement Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 45. Europe OTC Drug and Dietary Supplement Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe OTC Drug and Dietary Supplement Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 48. Asia-Pacific OTC Drug and Dietary Supplement Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 51. Latin America OTC Drug and Dietary Supplement Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America OTC Drug and Dietary Supplement Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 54. Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Powders
  • Capsules
  • Tablets
  • Liquids
Applications
  • Convenience Stores
  • Supermarkets
  • Pharmacies
Companies covered
  • Abbott
  • Pfizer
  • GSK
  • Bayer
  • Suntory
  • Reckitt Benckiser
  • Herbalife
  • Glanbia
  • Blackmores
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global OTC Drug and Dietary Supplement Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global OTC Drug and Dietary Supplement Market Size by Region (2021-2032)
  5. 1.4.1 Global OTC Drug and Dietary Supplement Market Size by Region (2021-2026)
  6. 1.4.2 Global OTC Drug and Dietary Supplement Market Size by Region (2027-2032)
  7. 1.5 Key Regions OTC Drug and Dietary Supplement Market Size (2021-2032)
  8. 1.5.1 North America OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa OTC Drug and Dietary Supplement Market Size Growth Rate (2021-2032)
2 OTC Drug and Dietary Supplement Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Powders
  3. 2.1.2 Capsules
  4. 2.1.3 Tablets
  5. 2.1.4 Liquids
  6. 2.2 Global OTC Drug and Dietary Supplement Market Size by Type
  7. 2.2.1 Global OTC Drug and Dietary Supplement Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global OTC Drug and Dietary Supplement Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global OTC Drug and Dietary Supplement Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global OTC Drug and Dietary Supplement Market Size by Regions
  11. 2.3.1 North America OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa OTC Drug and Dietary Supplement Market Size Breakdown by Type (2021-2026)
3 OTC Drug and Dietary Supplement Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Convenience Stores
  3. 3.1.2 Supermarkets
  4. 3.1.3 Pharmacies
  5. 3.2 Global OTC Drug and Dietary Supplement Market Size by Application
  6. 3.2.1 Global OTC Drug and Dietary Supplement Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global OTC Drug and Dietary Supplement Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global OTC Drug and Dietary Supplement Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global OTC Drug and Dietary Supplement Market Size by Regions
  10. 3.3.1 North America OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa OTC Drug and Dietary Supplement Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 OTC Drug and Dietary Supplement Industry Trends
  2. 4.2 OTC Drug and Dietary Supplement Industry Drivers
  3. 4.3 OTC Drug and Dietary Supplement Industry Opportunities and Challenges
  4. 4.4 OTC Drug and Dietary Supplement Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by OTC Drug and Dietary Supplement Revenue (2021-2026)
  2. 5.2 Global OTC Drug and Dietary Supplement Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global OTC Drug and Dietary Supplement Key Company Headquarters & Area Served
  4. 5.4 Global OTC Drug and Dietary Supplement Company, Product Type & Application
  5. 5.5 Global OTC Drug and Dietary Supplement Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global OTC Drug and Dietary Supplement Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 OTC Drug and Dietary Supplement Players Market Share by Revenue in 2025
  9. 5.6.3 2025 OTC Drug and Dietary Supplement Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GSK OTC Drug and Dietary Supplement Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Suntory
  26. 6.5.1 Suntory Company Information
  27. 6.5.2 Suntory Business Overview
  28. 6.5.3 Suntory OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
  30. 6.5.5 Suntory Recent Developments
  31. 6.6 Reckitt Benckiser
  32. 6.6.1 Reckitt Benckiser Company Information
  33. 6.6.2 Reckitt Benckiser Business Overview
  34. 6.6.3 Reckitt Benckiser OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
  36. 6.6.5 Reckitt Benckiser Recent Developments
  37. 6.7 Herbalife
  38. 6.7.1 Herbalife Company Information
  39. 6.7.2 Herbalife Business Overview
  40. 6.7.3 Herbalife OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
  42. 6.7.5 Herbalife Recent Developments
  43. 6.8 Glanbia
  44. 6.8.1 Glanbia Company Information
  45. 6.8.2 Glanbia Business Overview
  46. 6.8.3 Glanbia OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
  48. 6.8.5 Glanbia Recent Developments
  49. 6.9 Blackmores
  50. 6.9.1 Blackmores Company Information
  51. 6.9.2 Blackmores Business Overview
  52. 6.9.3 Blackmores OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
  54. 6.9.5 Blackmores Recent Developments
  55. 6.10 Amway
  56. 6.10.1 Amway Company Information
  57. 6.10.2 Amway Business Overview
  58. 6.10.3 Amway OTC Drug and Dietary Supplement Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Amway OTC Drug and Dietary Supplement Product Portfolio
  60. 6.10.5 Amway Recent Developments
7 North America
  1. 7.1 North America OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  3. 7.3 North America OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  3. 8.3 Europe OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  3. 10.3 South America OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst